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Abstract: Insulin/insulin-like growth factor-I (IGF-I) pathways are recognized as critical signaling pathways involved in 
the control of lifespans in lower organisms to mammals. Caloric restriction (CR) reduces plasma concentration of insulin, 
growth hormone (GH), and IGF-I. CR retards various age-dependent disorders such as nuerodegenerative diseases and ex-
tends lifespan in laboratory rodents. These beneficial effects of CR are partly mimicked in spontaneous or genetically en-
gineered rodent models of reduced insulin and GH/IGF-I axis. Most of these long-living rodents show increased insulin 
sensitivity; however, recent study has revealed that some other rodents show normal or reduced insulin sensitivity. Thus, 
increased insulin sensitivity might be not prerequisite for lifespan extension in insulin/GH/IGF-I altered longevity rodent 
models. These results highlighted that, for lifespan extension, the intracellular signaling molecules of insulin/GH/IGF-I 
pathways might be more important than actual peripheral or systemic insulin action.  
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INTRODUCTION 
  Compared to animals allowed to access food freely, 
moderate restriction of food intake, but not malnutrition, 
reduces morbidity and mortality in laboratory animals [1]. 
This effect, often noted as the anti-aging effects of caloric 
restriction (CR), has been recognized as a result from the 
restriction of calorie intake, but not from the restriction of a 
specific food component and not from a reduction of the 
toxic contaminants in food [2,3]. From an evolutionary 
viewpoint, the effect of CR appears to be explained by or-
ganisms having evolved adaptation mechanisms in their neu-
roendocrine systems to maximize survival during periods of 
food shortage [4]. Thus, it is believed that CR can, at least in 
part, regulate the aging processes through its effects on en-
docrine and/or neural regulatory systems [2]. The underlying 
molecular mechanism of regulation of the neuroendocrine 
system by CR remains to be fully elucidated; however, insu-
lin, the GH/IGF-I axis, and leptin have been proposed as 
potential molecular mediators of the adaptive response to CR 
[5-8].  
  In many rodents, spontaneously or targeted gene modifi-
cations of insulin and the GH/IGF-I axis results in lifespan 
extension (see review [9-12]). Thus CR and these rodent 
insulin/GH/IGF-I models share, at least in part, a molecular 
mechanism of longevity. However, CR has been shown to 
also extend lifespan in GH-deficient long-lived Ames dwarf 
mice [13]. Furthermore, we found that CR significantly ex-
tended the lifespan of pituitary specific GH-antisense trans- 
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genic (TG) rats, which have reduced plasma levels of insulin 
and IGF-I [14,15]. These findings suggest that there might 
be different pathways in lifespan extension by GH/IGF-I 
suppression and CR; although it is possible that they share 
some of the same regulatory molecules in the insu-
lin/GH/IGF-I pathway. 
  In lower organisms, long-lived mutants in C. elegans 
have provided a body of evidence about molecular mecha-
nisms underlying longevity [16]. The C. elegans neurosecre-
tory signaling system regulates whether animals enter the 
reproductive life cycle or have an arrest in development at 
the long-lived dauer diapause stage. The daf-2 gene encodes 
an insulin/IGF-I like receptor, a critical gene in the genetic 
pathway that mediates this endocrine signaling in C. elegans 
[17]. The age-1 gene [18] acts in the same signaling pathway 
as daf-2, and is closely related to a family of mammalian 
phosphatidylinositol 3-kinase (PI3K) p110 catalytic subunits 
under the insulin/IGF-I signaling pathway [19]. It has been 
also reported that mutations in the Drosophila equivalents of 
daf-2 (InR), and chico, a fruit fly insulin receptor substrate 
(IRS), indicate that these genes have roles in body and organ 
size determination as well as in lifespan [20,21]. Reduction 
of function in InR mutants and the null mutation of chico 
increased the mean lifespan in female flies. These findings 
suggest that insulin/IGF-I signaling is a highly conserved 
longevity signal from lower to higher organisms. 
  In this brief review, we first discuss longevity rodent 
models that have modified insulin/GH/IGF-I pathways. 
These include spontaneous dwarf mutations and genetically 
altered rodents with increased lifespan. Later, we speculate 
the involvement of WD-repeat protein 6 (WDR6) as a candi-
date for the regulator of insulin/IGF-I signaling, which con-
trols metabolism and longevity in the brain [22]. 424    Current Genomics, 2007, Vol. 8, No. 7  Chiba et al. 
Insulin and GH/IGF-I Axis in Rodent Longevity Models 
 Table  1 shows rodent longevity models with modified 
insulin/GH/IGF-I signals. In mammals, the production of 
IGF-I is stimulated by pituitary GH. Prop-1 (Ames mice) 
and pit-1 (Snell mice) mutant dwarf mice live longer than 
controls, with defects of transcription factors controlling 
differentiation of the anterior pituitary during fetal develop-
ment [23]. These mice are also prolactin (PRL) and thyroid-
stimulating hormone (TSH) deficient. However, it is thought 
that inhibition of the GH/IGF-I axis is the primary effector 
on lifespan extension of these mice because GH overexpres-
sion mice show resemble an accelerated aging phenotype, 
with a shorter lifespan and earlier loss of fertility [24]. Both 
Ames and Snell mice show increased insulin sensitivity 
[25,26].  
  Another pituitary mutation that causes dwarfism was 
found in lit/lit mice. The responsive gene in these mice is the 
GH-releasing hormone receptor (Ghrhr) [27]. Ghrhr
lit/lit mice 
have low levels of GH, IGF-I with prolonged lifespan [28]. 
Data from the Ghrhr
lit/lit mice also suggest that changes in 
the GH/IGF-I axis could be sufficient to extend lifespan of 
dwarf mice, because these mice have normal PRL, TSH and 
thyroid hormone levels. Ghrhr
lit/lit mice appear to have nor-
mal insulin responses compared to wild type mice [29]. 
However, double mutant mice of Ghrhr and PRL-receptor 
showed decreased insulin sensitivity in old age because of 
increased adiposity [29]. This contrasts with the results of 
the GH- and PRL-deficient Ames and Snell mice described 
above.  
  Pituitary specific GH-antisense TG rats show increase 
lifespan with lower serum insulin, IGF-I compared to Wistar 
rats, which have same genetic background [14,15]. These 
rats have increased insulin action to reduce blood glucose; 
however, insulin-independent glucose-lowering effects have 
also been suggested [30,31]. These rats show a moderate 
reduction of the GH/IGF-I axis compared to Ames or Snell 
dwarf mice whose GH/IGF-I axis is almost completely sup-
pressed. Similar to these dwarf mice, CR upon GH-antisense 
TG rats have an extended lifespan with further reduction of 
insulin/IGF-I levels [14].  
  The murine equivalents to human Laron syndrome are 
GH receptor/binding protein homozygous knockout mice 
(GHR/BP
-/-) [32]. The human and murine GHR/BP gene en-
codes for two proteins; GH receptor and GH receptor bind-
ing protein, a truncated form of a receptor. GHR/BP KO 
mice have a longer lifespan compared to control wild type 
mice [33]. These mice have a markedly reduced plasma con-
centration of IGF-I, and a dwarf phenotype with increased 
insulin sensitivity [33,34]. GHR/BP deficiency impairs the 
beneficial effects of CR on lifespan extension and increases 
insulin sensitivity [35]. As well, CR increases insulin sensi-
tivity in control mice, but does not further increase insulin 
sensitivity in GHR/BP
-/- mice [35]. 
  In the knockout mice heterozygous for the IGF-I receptor 
(Igf1r
+/-), significant lifespan extension was observed in fe-
male mice, whereas homozygous knockout mice died at 
birth, probably as a result of respiratory failure [36]. The 
body size of these mice is almost normal and they have no 
detectable alterations in reproductive development and func-
tion. Male Igf1r
+/-  mice show reduced insulin sensitivity, 
whereas females showed increased insulin sensitivity [36]. 
Mouse embryonic fibroblasts (MEFs) from Igf1r
+/- mice 
show reduced IGF-I receptor (IGF-IR) signaling in response 
to IGF-I addition compared to MEFs from wild type mice 
[36]. Namely, tyrosine phosphorylation levels of IGF-IR, 
IRS-1, and p66
shc proteins are decreased in MEFs from 
Igf1r
+/- mice. Moreover, it has been documented that brain 
specific heterozygous IGF-IR knockout mice have an in-
creased lifespan and a significant decrease in mortality rate 
[37]. This is interesting because importance of brain insu-
lin/IGF-I signaling is also suggested in C. elegans and Dro-
sophila [37]. 
Table 1.  Rodent Longevity Models of Modified Insulin/GH/IGF-I Signaling 
Rodent Models Responsive Gene Effect
a Lifespan
b Body Weight
c IGF-I Insulin Sensitivity
Ames mice Prop-1 Pituitary 49%, 68% 33% Decreased Increased
Snell mice Pit-1 Pituitary 26%, 42% 33% Decreased Increased
Ghrhr
lit/lit mice  Ghrhr Pituitary 23%, 25% 67% Decreased Unchanged
GH-antisense TG rats GH-antisense Pituitary 10% 66% Decreased Increased
GHR/BP
-/- mice GHR/BP Receptor 55%, 38% 40-41% Decreased Increased
Igf1r
+/- mice Igf1r Receptor 33% 92-94% Increased Increased
FIRKO mice IR (fat-specific) Receptor +18% 75-85% Unchanged Increased
p66
shc-/- mice p66
shc Intracellular +30% 100% Unknown Unknown
Irs1
-/- mice Irs1 Intracellular 32% 60-65% Unchanged Decreased
bIrs2
+/- mice Irs2 (brain-specific) Intracellular 18% 95-100% Unknown Decreased
a Site of primary effect of the mutation. 
b % increase of lifespan in mutants compared to control animals. 
c % of body weight compared to control animals (6 to 10 months old). Rodent Longevity Models  Current Genomics, 2007, Vol. 8, No. 7    425 
  Fat specific insulin receptor knock out mice (FIRKO 
mice) show increased lifespan without reduction of the 
plasma IGF-I levels [38,39]. These mice show reduced body 
fat content, body mass index, and resistant to age-related and 
hyperphagia-induced insulin resistance. In adipose tissue, 
insulin-stimulated glucose uptake was reduced in FIRKO 
mice, indicating that insulin signaling is markedly decreased 
in the adipose tissue of these mice. However, whole body 
insulin sensitivity is increased in FIRKO mice probably as a 
result of the increased plasma adiponectin levels, especially 
in aged mice [38,39]. Recent study has revealed that FIRKO 
mice maintain high mitochondrial capacity and metabolic 
rates in adipose tissue [40]. These increased mitochondrial 
functions may be important for the lifespan extension seen in 
the FIRKO mouse. 
  Proto-oncogene Shc, an adaptor protein of receptor tyro-
sine kinase, is phosphorylated by the activation of growth 
factor receptors such as IGF-IR and insulin receptor (IR); a 
knock out mouse strain of the p66 isoform of Shc, p66
shc 
showed a prolonged lifespan and increased oxidative stress 




shc [42]. MEFs from 
p66
shc knock out mice show more resistance to hydrogen 
peroxide treatment or UV radiation compared to MEFs from 
wild type mice [41]. This effect partly is mediated the induc-
tion of FoxO3a, a mammalian homologue of the C. elegans 
forkhead transcription factor daf-16 [43]. This is interesting 
because daf-16 is essential for lifespan extension in the daf-2 
mutant [44]. No information is yet available about the insulin 
sensitivity of p66
shc-/- mice. 
  IRS-1 knock out (Irs1
-/-) female mice show increased 
lifespan despite moderate insulin resistance [45]. Same as 
Igf1r
+/- mice, Irs1
-/- mice lifespan extension is predominantly 
seen in females. The body weight of these mice is lower than 
that of wild type; however, serum IGF-I levels are not differ-
ent. These mice show reduced adiposity similar to CR and 
FIRKO mice; however, Irs1
-/- mice show moderate insulin 
resistance. Thus, the improvement in insulin sensitivity asso-
ciated with reduced fat mass is not a prerequisite for the 
lifespan extension of Irs
-/- mice [45]. Tyrosine phosphoryla-
tion of IRS-1 enhances insulin sensitivity, whereas serine 
phosphorylation of IRS-1 by S6 kinase induces insulin resis-
tance [46]. Therefore, IRS-1 has both negative and positive 
effects on insulin/IGF-I signaling. Lack of IRS-1 might 
cause predominately favorable intracellular signaling situa-
tions for cell survival causing lifespan extension through the 
activation of the FoxO1 protein, a forkhead transcription 
factor important for oxidative stress response. 
  IRS-2 heterozygous knock out mice, specifically in brain 
(bIrs2
+/-), showed increased lifespan [47]. Interestingly, 
while systemic heterozygous IRS-2 deficiency improved 
insulin sensitivity, brain-specific IRS-2 knock out led to in-
sulin resistance. Although the mechanism responsible for 
this discrepancy is unknown, these results also support that 
insulin sensitivity by itself is not a prerequisite for lifespan 
extension in insulin/GH/IGF-I signal modified longevity 
rodents. Similar to IRS-1, tyrosine phosphorylation of IRS-2 
by IR or IGF-IR is the first event in the activation of the in-
tracellular insulin/IGF-I signal transduction pathway. IRS-1 
and IRS-2 are the major IRS leading to glucose homeostasis, 
and have distinct and overlapping roles in diverse organs 
[48]. Lifespan extension in bIrs2
+/- mice might be related to 
the FoxO1 protein levels maintained in the brain that lead to 
the expression of antioxidant protein SOD2 [47]. These re-
sults of lifespan extension of bIrs2
+/- as well as Irs1
-/- mice 
might suggest that the mutation of particular molecules of 
intracellular insulin/IGF-I signaling is sufficient to induce 
longevity. Therefore, a reduced GH/IGF-I axis in dwarf ani-
mals and long-lived insulin/GH/IGF-I receptor modified 
mice might eventually change the activation of these intra-
cellular substrate molecules including p66
shc and their down-
stream targets for lifespan extension. Hence, reduced body 
size and increased insulin sensitivity might not be important 
and so could be separated from factors responsible for 
lifespan extension in such animals. 
  In summary, the above mentioned models suggest that 
decreased body weight and increased insulin sensitivity 
might be not prerequisites for lifespan extension in insu-
lin/GH/IGF-I modified longevity rodents. Although there a 
significant effect on body weight and insulin sensitivity were 
seen depending on the particular factors in the breeding envi-
ronments used in the study, such as diet composition, the 
results presented highlight that the importance of the intra-
cellular signaling molecules of the insulin/GH/IGF-I signal 
rather than the upstream hormonal signals. Fig. (1) shows the 
sites of mutations in rodent longevity models. Pituitary GH 
and insulin/GH/IGF-I receptor mutations might cause favor-
able situations for intracellular signaling molecules, such as 
reduction of function IRS-1, -2 and p66
shc, because knock 
out of these intracellular molecules extends lifespan. Re-
cently, we isolated WDR6, a novel candidate for the intracel-
lular insulin/IGF-I signaling molecule. Next we discuss the 
potential involvement of WDR6 in lifespan regulation.  
WDR6 as a New Candidate for an Insulin/GH/IGF-I Sig-
naling Molecule Related to Lifespan Regulation 
  We recently isolated and identified WDR6 as a novel 
molecule involved in hypothalamic insulin/IGF-I signaling 
with interacting IRS-4 by cDNA subrtaction method [22, 
49]. IRS-1 and IRS-2 are ubiquitously expressed, while IRS-
3 and IRS-4 are tissue specific, detected in significant 
amounts in fat and brain tissue, respectively [50]. IRS-4 is 
expressed abundantly in the arcuate nucleus, an important 
hypothalamic nucleus for regulation of energy and metabo-
lism [51]. We found that the expression of WDR6 was de-
creased in vivo upon CR as well as with suppression of the 
GH/IGF-I axis; both treatments cause reductions of plasma 
insulin/IGF-I concentrations. Our in vitro study indicated 
that the addition of insulin or IGF-I caused increased gene 
expression of WDR6 in GT1-7 cells, a mouse hypothalamus 
derived cell line [22,52]. These results suggested the pres-
ence of a feedback loop for insulin/IGF-I-mediated expres-
sion of WDR6. 
  WD repeats are conserved domains of approximately 40 
to 60 amino acids that contain a tryptophan-aspartic acid 
(WD) dipeptide at their C-terminus, and have a conserved 
core sequence [53,54]. WDR6 was first cloned by Li et al, 
[55]. They showed that human WDR6 has 11 WD-repeat 
domains and shows relatively ubiquitous expression. How-
ever, we isolated the WDR6 gene in brain as a hypothalamus 426    Current Genomics, 2007, Vol. 8, No. 7  Chiba et al. 
enriched gene [22] by using a cDNA subtraction method 
[49,56,57]. This expression pattern of WDR6 is consistent 
with another report that used a DNA microarray analysis 
[58]. WD repeat domains are involved in mediating protein-
protein interactions [59,60], and WD repeat-containing pro-
teins have a central role in many signal transduction cascades 
by coordinating the interaction of key signaling molecules.  
  We found that IRS-4 interacts with WDR6 in vivo. Our 
results suggested that WDR6 might regulate phosphorylation 
levels of the interacting protein, IRS-4 [22]. Interestingly, it 
was suggested that WDR6 and IRS-4 might also be involved 
in fibroblast growth factor (FGF) signaling [61]. Stimulation 
with FGF2 induced a 3-fold increase in tyrosine phosphory-
lated proteins, as assessed by mass spectrometry [61]. It has 
been suggested that FGF2 has an inhibitory effect on food 
intake and locomotor activity in rats [62]. Taken together, 
these results suggest that WDR6 may be involved in feeding 
and physical activities through its interaction in the brain 
with IRS-4.  
  Mice lacking IRS-4 show mild defects in growth, repro-
duction and glucose homeostasis [63]. These mice show 
slightly impaired responses on the oral glucose tolerance 
test. The insulin tolerance testing also showed these mice 
slightly less responsive to insulin compared to wild type; 
however, the effect was statistically insignificant. It was 
suggested that loss-of-function of IRS-4 in the brain might 
cause these phenotypes, because IRS-4 is predominantly 
expressed in the brain [63]. These phenotypes are somewhat 
similar to long-lived Irs1
-/- and bIrs2
+/- mice. Study is needed 
to find out whether WDR6 also interacts with IRS-1 and 
IRS-2.  
  It has recently been shown that WDR6 interacts with 
LKB1, a tumor suppressor gene encoding a serine/threonine 
kinase that phosphorylates AMP-activated protein kinase 
(AMPK), and regulates p27
Kip1 induction [64]. AMPK is a 
critical component in a protein kinase cascade that have a 
crucial role in the regulation of energy balance, particularly 
in the brain [65,66]. LKB1 gene expression is enriched in the 
hypothalamus, similar to the WDR6 gene in the brain [58]. 
The LKB1-AMPK-p27 pathway is also involved in the 
autophagic response, a bulk misfolded protein degradative 
system [67]. In C. elegans, autophagy genes are essential for 
dauer development and for lifespan extension in the daf-2 
mutant [68]. Moreover, autophagy mediates lifespan exten-
sion of C. elegans upon CR [69]. Autophagy is also reported 
to be important in lifespan extension in Drosophila [70]. In 
mammals, the induction of autophagy is a protective re-
sponse against neurodegenerative diseases [71,72]. Moreo-
ver, CR prevents the age-dependent decline of autophagic 
proteolysis in liver cells [73]. Thus, it is interesting to specu-
late that WDR6 also regulates autophagy responses by 
modulating the LKB1-AMPK pathway in the brain. Further 
studies using genetically modified mice such as conditional 
















Fig. (1). Mammalian GH and insulin/IGF-I signaling pathways. Longevity related genes shown in Table 1 and discussed in text are shown in 
outlined characters on a gray background. Pituitary mutations cause GH/IGF-I-deficiency results in dwarf phenotypes, and increased insulin 
sensitivity in most cases. Mutations of receptors and intracellular signaling molecules are not necessary to increase insulin sensitivity for 
lifespan extension. These intracellular molecules could be points of intervention for therapies with the potential to delay the aging process. Rodent Longevity Models  Current Genomics, 2007, Vol. 8, No. 7    427 
precise mechanism of WDR6 involvement in AMPK signal-
ing as well as in insulin/IGF-I signaling in longevity. 
  In conclusion, increased insulin sensitivity might not be a 
prerequisite for lifespan extension in insulin/GH/IGF-I modi-
fied rodent longevity models. Although it is possible that 
different tissues show different insulin sensitivity in these 
longevity models, there could be more important intracellu-
lar signaling molecules in insulin/GH/IGF-I signaling, such 
as IRS-1, -2, and p66
shc, and possibly WDR6, for lifespan 
extension. These molecules could be points of intervention 
for therapies with potential to delay the pathogenesis of age-
related diseases and even the aging process. Further study is 
needed to reveal the importance, if any, of these molecules 
through identification of target transcription factors critical 
for lifespan extension. 
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